跳到主要导航 跳到搜索 跳到主要内容

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19

科研成果: 期刊稿件 › 综述 › 同行评审

48 引用 (Scopus)

摘要

A novel coronavirus, later named SARS-CoV-2, was first reported in China in December 2019 and subsequently widely identified in the United States, Japan, South Korea, France, India, and other countries. The disease caused by SARS-CoV-2 infection was called COVID-19. The high fatality and morbidity rates of COVID-19 make it the third largest global epidemic in this century. However, there are currently no approved antiviral drugs for the COVID-19 treatment. Recently, two old antimalarial drugs, hydroxychloroquine and chloroquine, have been found to exert anti-SARS-CoV-2 effects both in vitro and in vivo. Preliminary clinical evidence suggests these drugs may have an effect on the treatment of COVID-19. Herein, we review the pharmacokinetics characteristics and antiviral effects of these drugs, in addition to their side effects and clinical evidence of their use for the COVID-19 treatment.
源语言英语
页(从-至)765-772
页数8
期刊Archives of Pharmacal Research
卷43
期8
DOI
出版状态已出版 - 8月 2020

基金资助

This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81822016 and 81771382) to Zhentao Zhang.

关键词

  • Hydroxychloroquine
  • Chloroquine
  • COVID-19
  • SARS-CoV-2
  • Treatment

收录

  • SCIE
  • Scopus

学术指纹

探究 'Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19' 的科研主题。它们共同构成独一无二的学术指纹。

引用此